Pharmaceutical

AstraZeneca posts $2.18bn profit after tax in Q1 2024

AstraZeneca has reported profit after tax of $2.18bn for the first quarter (Q1) of 2024, a notable rise from $1.80bn reported in the same period last year.

Apr 27, 2024 - 00:00
AstraZeneca posts $2.18bn profit after tax in Q1 2024
AstraZeneca has reported profit after tax of $2.18bn for the first quarter (Q1) of 2024, a notable rise from $1.80bn reported in the same period last year.
Read the original article

Tags:

Previous Article

Regeneron and Mammoth team up to develop gene editing therapies

Next Article

Sanders takes aim at US drug prices of Novo’s Ozempic and Wegovy

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Amylyx considers scrapping ALS drug following Phase III flop

Amylyx considers scrapping ALS drug following Phase III...

Mar 9, 2024

No longer brushed off: A Minnesota clinic tries to rewrite medicine’s approach to miscarriage

No longer brushed off: A Minnesota clinic tries to rewr...

Aug 31, 2023

STAT+: Patent thickets and terminal disclaimers: How pharma blocks biosimilars from the marketplace

STAT+: Patent thickets and terminal disclaimers: How ph...

Dec 21, 2023